COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
DentalXChange Partners With Zentist to Bring AI-Driven Insurance Payment Reconciliation to DentalXChange Clients
DentalXChange announces a strategic partnership with Zentist, integrating Remit AI's automated payment reconciliation technology to manage dental insurance claims payments. The end-to-end solution aims to improve efficiency and reduce costs for multi-site dental service groups -
-
COMMUNIQUÉ DE PRESSE
Financial Independence Group Announces Keith Burger as Executive Vice President, Institutional Channel
Financial Independence Group (FIG) appoints Keith Burger as new executive vice president, institutional channel. Burger will strengthen alliances and form new partnerships to expand the company's distribution footprint -
-
COMMUNIQUÉ DE PRESSE
Austin MHC Implements NewOrg Platform for Member Management, Support Group Attendance, and Peer Mentorship Documentation
AMHC supports and advocates for peers' right to mental wellness and self-sufficiency with the help of NewOrg Data Management System. Austin MHC, a non-profit based in Texas, provides resources and services for mental health issues -
-
COMMUNIQUÉ DE PRESSE
Premier and Concentra Meet Rising Demand in Occupational Radiology
Premier Radiology Services extends long-term contract with Concentra, the nation's largest occupational medicine provider, through 2030 to deliver fast and accurate radiology interpretations for urgent and occupational health care services -
COMMUNIQUÉ DE PRESSE
MixPlaces Launches Improved Custom Map Prints Users Can Personalize in Minutes
Miami-based MixPlaces launches new and improved custom map prints, including street, topographic, and terrain map posters with customizable routes and over 20 additional features. These feature-rich maps make the perfect personalized gift for anyone -
COMMUNIQUÉ DE PRESSE
Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease
Cantabio Pharmaceuticals, Inc. receives major grant from MJFF for the development of DJ-1 replacement therapy aimed at treating Parkinson's disease by increasing DJ-1 levels in patients and preventing disease progression
